Eribulin mesylate bulk supplier for pharma manufacturers

Eribulin Mesylate Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 0.44 mg/mL

Reference Brands: HALAVEN (USA/EU)

Category: Oncology Cancer Care

Eribulin mesylate is available in Injection and strengths such as 0.44 mg/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Eribulin mesylate is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Technical Specifications & Supply Details
Lead Time 7 to 60 days (depending on batch size & schedule)
MOQ As per manufacturer’s batch size
COA Available with every batch
Regulatory Dossier / DMF Available upon request
Export Documentation FSC, COA, Manufacturing License, Product Permission
Standards IP, BP, USP
Certifications WHO-GMP, EU-GMP, USFDA (as applicable)

Eribulin mesylate can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

What is Eribulin mesylate made from? Eribulin mesylate is made from a synthetic analog of halichondrin B, a compound originally derived from the marine sponge Halichondria okadai. It is a microtubule dynamics inhibitor that targets cancer cells.

What is trade name of Eribulin mesylate? The trade name of Eribulin mesylate is Halaven.

What company makes Eribulin mesylate? Eribulin mesylate (Halaven) is manufactured by Eisai Co., Ltd. and marketed globally in collaboration with other licensed pharmaceutical distributors.

What is generic name of Eribulin mesylate? The generic name of Eribulin mesylate is Eribulin mesylate.

What is brand name of Eribulin mesylate? The brand name of Eribulin mesylate is Halaven.

Where is Eribulin mesylate manufactured? Eribulin mesylate is manufactured in Japan and other countries by Eisai Co., Ltd. under strict GMP-certified conditions for oncology therapeutics.

Yes, Eribulin mesylate is available with DMF and other regulatory documents such as COA and MSDS. These can be provided upon request for qualified buyers.

Absolutely. Sample requests are accepted for formulation trials and quality checks. Please submit an enquiry to initiate the process.

Our manufacturing partners are GMP-certified and comply with ISO and WHO standards, ensuring global quality benchmarks.

Lead times vary based on quantity and destination, but most orders are fulfilled within 1–3 weeks. Express shipping options are available.

Yes, Eribulin mesylate is exported to over 30 countries across Asia, Africa, Europe, and Latin America. We support documentation for customs and regulatory clearance.

Related Products

Dostarlimab-Gxly

Strength:
500 mg

Form: Injection

Reference Brands: Jemperli(USA/EU)

View Details
Mitomycin Pyelocalyceal

Strength:
40 mg

Form: Injection

Reference Brands: Jelmyto (USA/EU)

View Details
Pirtobrutinib

Strength:
50mg, 100mg

Form: Tablets

Reference Brands: Jaypirca(USA/EU)

View Details
Ixabepilone

Strength:
15 mg, 45mg

Form: Injection

Reference Brands: Ixempra (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.